Safety of Dose Escalation by Simultaneous Integrated Boosting Radiation Dose in Unresectable Stage III Non-Small Cell Lung Cancer

被引：0
|
作者：
Zhang, Q. [1 ]
Fu, X. [1 ]
机构：
[1] Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Shanghai, Peoples R China
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2016年 / 96卷 / 02期
关键词：
D O I：
10.1016/j.ijrobp.2016.06.373
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
348
引用
收藏
页码：S154 / S155
页数：2
相关论文
共 50 条
  • [31] Concurrent chemoradiotherapy for unresectable stage III non-small cell lung cancer
    Vokes, EE
    Crawford, J
    Bogart, J
    Socinski, MA
    Clamon, G
    Green, MR
    CLINICAL CANCER RESEARCH, 2005, 11 (13) : 5045S - 5050S
  • [32] The safety and efficacy of induction chemoimmunotherapy in initially unresectable stage III non-small cell lung cancer
    Tang, Min
    Zhao, Zhe
    Zhang, Ping
    Nie, Xin
    Wu, Xiaonan
    Yuan, Yue
    Liu, Lian
    Liu, Lipin
    Jiao, Peng
    Li, Lin
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [33] Final report of a phase I radiation dose escalation study in patients with inoperable/unresectable non-small cell lung cancer: predictors for radiation pneumonitis
    Kong, F.
    Hayman, J.
    Ten Haken, R.
    Kelemkerian, G.
    Arenberg, D.
    Lyons, S.
    Turrisi, A.
    Lichter, A.
    Eishbruch, A.
    Lawrence, T.
    EJC SUPPLEMENTS, 2005, 3 (02): : 391 - 391
  • [34] Radiation dose escalation in patients with non-small cell lung cancer facilitated by the use of the cytoprotectant amifostine
    Nichols, R
    Neuenfeldt, L
    England, G
    Mahmood, S
    Nanfro, J
    Malamud, F
    Sweetser, M
    Varner, J
    LUNG CANCER, 2005, 49 : S312 - S312
  • [35] Radiation Dose is Important for Overall Survival in Patients with Inoperable or Unresectable Non-small Cell Lung Cancer
    Gustitus, D.
    Cai, X.
    Bowman, N.
    Kempf, L.
    Kong, F.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 75 (03): : S475 - S475
  • [36] Hypofractionated (chemo)radiation delivered with helical tomotherapy allows safe dose escalation in stage Ill unresectable non small cell lung cancer
    Arcangeli, S.
    Monaco, A.
    Caruso, C.
    Cianciulli, M.
    Chiostrini, C.
    Rauco, R.
    Pressello, M. C.
    Donato, V.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S809 - S809
  • [37] Radiation dose escalation in limited-stage small-cell lung cancer
    Roof, KS
    Fidias, P
    Lynch, TJ
    Ancukiewicz, M
    Choi, NC
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2003, 57 (03): : 701 - 708
  • [38] Paclitaxel and simultaneous radiation in the treatment of stage III A/B non-small cell lung cancer
    Havemann, K
    Wolf, M
    Goerg, C
    Faoro, C
    Pfab, R
    Diergarten, K
    SEMINARS IN ONCOLOGY, 1995, 22 (06) : 19 - 22
  • [39] Daily subcutaneous Amifostine facilitates radiation dose escalation for poor risk unresectable stage III lung cancer
    Videtic, G. M.
    Desai, A.
    Reddy, C.
    Kalmadi, S.
    Mekhail, T.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 69 (03): : S487 - S488
  • [40] Stage III Non-Small Cell Lung Cancer Treated Without Concurrent Chemotherapy: What Is the Optimal Radiation Dose?
    Rimner, A.
    Din, S.
    Shaikh, F.
    Foster, A.
    Tyagi, N.
    Aad, S. Abi
    Paik, P.
    Yorke, E. D.
    Chaft, J. E.
    Gelblum, D. Y.
    Rosenzweig, K. E.
    Wu, A. J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S23 - S23
12345